Anna Polesskaya

Anna Polesskaya

Auto-generated profile, based on publicly available information

Anna Polesskaya

CNRS FRE 3377, CEA Saclay, F-91191 Gif-sur-Yvette, France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2013 in BMC Genomics
Verified
Journal Article
Open access
PDF file
PDPetr Dmitriev
Petr Dmitriev
ABAna Barat
Ana Barat
APAnna Polesskaya
Anna Polesskaya
MOMary J O’cOnnell
Mary J O’cOnnell
TRThomas Robert
Thomas Robert
Yegor VassetzkyYegor Vassetzky
Yegor Vassetzky
Background: miRNA profiling performed in myogenic cells and biopsies from skeletal muscles has previously identified miRNAs involved in myogenesis.Results: Here, we have performed miRNA transcriptome profiling in human affinity-purified CD56+ myoblasts induced to differentiatein vitro. In total, we have identified 60 miRNAs differentially expressed during myogenic differentiation. Many were not known for being differentially expressed during myogenic differentiation. Of these, 14 (miR-23b, miR-28, miR-98, miR-103, miR-107, miR-193a, miR-210, miR-324-5p, miR-324-3p, miR-331, miR-374, miR-432, miR-502, and miR-660) were upregulated and 6 (miR-31, miR-451, miR-452, miR-565, miR-594 and miR-659) were downregulated. mRNA transcriptome profiling performed in parallel resulted in identification of 6,616 genes differentially expressed during myogenic differentiation.Conclusions: This simultaneous miRNA/mRNA transcriptome profiling allowed us to predict with high accuracy target genes of myogenesis-related microRNAs and to deduce their functions.

29 January 2015 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
SMSwanhild U Meyer
Swanhild U Meyer
CTChristian Thirion
Christian Thirion
APAnna Polesskaya
Anna Polesskaya
SBStefan Bauersachs
Stefan Bauersachs
SKSebastian Kaiser
Sebastian Kaiser
Michael W. PfafflMichael W. Pfaffl
Michael W. Pfaffl
Elevated levels of the inflammatory cytokine TNF-α are common in chronic diseases or inherited or degenerative muscle disorders and can lead to muscle wasting. By contrast, IGF1 has a growth promoting effect on skeletal muscle. The molecular mechanisms mediating the effect of TNF-α and IGF1 on muscle cell differentiation are not completely understood. Muscle cell proliferation and differentiation are regulated by microRNAs (miRNAs) which play a dominant role in this process. This study aims at elucidating how TNF-α or IGF1 regulate microRNA expression to affect myoblast differentiation and myotube formation. In this study, we analyzed the impact of TNF-α or IGF1 treatment on miRNA expression in myogenic cells. Results reveal that i) TNF-α and IGF1 regulate miRNA expression during skeletal muscle cell differentiation in vitro, ii) microRNA targets can mediate the negative effect of TNF-α on fusion capacity of skeletal myoblasts by targeting genes associated with axon guidance, MAPK signalling, focal adhesion, and neurotrophin signalling pathway, iii) inhibition of miR-155 in combination with overexpression of miR-503 partially abrogates the inhibitory effect of TNF-α on myotube formation, and iv) MAPK/ERK inhibition might participate in modulating the effect of TNF-α and IGF1 on miRNA abundance. The inhibitory effects of TNF-α or the growth promoting effects of IGF1 on skeletal muscle differentiation include the deregulation of known muscle-regulatory miRNAs as well as miRNAs which have not yet been associated with skeletal muscle differentiation or response to TNF-α or IGF1. This study indicates that miRNAs are mediators of the inhibitory effect of TNF-α on myoblast differentiation. We show that intervention at the miRNA level can ameliorate the negative effect of TNF-α by promoting myoblast differentiation. Moreover, we cautiously suggest that TNF-α or IGF1 modulate the miRNA biogenesis of some miRNAs via MAPK/ERK signalling. Finally, this study identifies indicative biomarkers of myoblast differentiation and cytokine influence and points to novel RNA targets.

6 February 2015 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
JKJeremie Kropp
Jeremie Kropp
CDCindy Degerny
Cindy Degerny
NMNadezda Morozova
Nadezda Morozova
JPJulien Pontis
Julien Pontis
AHAnnick Harel-Bellan
Annick Harel-Bellan
APAnna Polesskaya
Anna Polesskaya
A genome-wide screen had previously shown that knocking down miR-98 and let-7g, two miRNAs of the let-7 family, leads to a dramatic increase in terminal myogenic differentiation. In the present paper, we report that a transcriptomic analysis of human myoblasts, where miR-98 was knocked down, revealed that approximately 240 genes were sensitive to miR-98 depletion. Among these potential targets of miR-98, we identified the transcriptional repressor E2F5 and showed that it is a direct target of miR-98. Knocking down simultaneously E2F5 and miR-98 almost fully restored normal differentiation, indicating that E2F5 is involved in the regulation of skeletal muscle differentiation. We subsequently show that E2F5 can bind to the promoters of two inhibitors of terminal muscle differentiation, ID1 (inhibitor of DNA binding 1) and HMOX1 (heme oxygenase 1), which decreases their expression in skeletal myoblasts. We conclude that miR-98 regulates muscle differentiation by altering the expression of the transcription factor E2F5 and, in turn, of multiple E2F5 targets.

5 March 2014 in FEBS Letters
Verified
Journal Article
Closed access
SBS. Boudoukha
S. Boudoukha
TVT. Rivera Vargas
T. Rivera Vargas
IDI. Dang
I. Dang
JKJ. Kropp
J. Kropp
SCS. Cuvellier
S. Cuvellier
APA. Polesskaya
A. Polesskaya

15 October 2007 in médecine/sciences
Verified
Journal Article
Closed access
APAnna Polesskaya
Anna Polesskaya
AHAnnick Harel-Bellan
Annick Harel-Bellan

1 February 2010
Verified
Journal Article
Closed access
AHAnnick Harel-Bellan
Annick Harel-Bellan
MAMaya Ameyar
Maya Ameyar
APAnna Polesskaya
Anna Polesskaya
CDcindy degerny
cindy degerny